Tkg Advisors, LLC Eli Lilly & CO Transaction History

Tkg Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$321.55 - $374.67 $55,628 - $64,817	173 Added 5.32%	3,426 $1.25 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $1.22 Million - $1.39 Million	-4,106 Reduced 55.8%	3,253 $1.05 Million
Q2 2022 Jul 15, 2022	BUY	$278.73 - $327.27 $115,115 - $135,162	413 Added 5.95%	7,359 $2.39 Million
Q1 2022 Apr 15, 2022	BUY	$234.69 - $291.66 $145,742 - $181,120	621 Added 9.82%	6,946 $1.99 Million
Q4 2021 Jan 20, 2022	BUY	$224.85 - $279.04 $1.42 Million - $1.76 Million	6,325 New	6,325 $1.75 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Tkg Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Tkg Advisors, LLC with notifications on news.